Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Yi Shen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Epigenomics|September 2, 2020
Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatmentMadonna R Peter, Misha Bilenky, Ruth Isserlin, et al.
Neuro-Oncology|December 1, 2022
Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classificationJeffrey A Zuccato, Vikas Patil, Sheila Mansouri, et al.
Frontiers in Immunology|August 21, 2023
The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell populationTiago S Medina, Alex Murison, Michelle Smith, et al.
Genome Biology|January 8, 2024
Modeling methyl-sensitive transcription factor motifs with an expanded epigenetic alphabetCoby Viner, Charles A Ishak, James Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2021
Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell CarcinomaJustin M Burgener, Jinfeng Zou, Zhen Zhao, et al.
Nature Communications|October 30, 2022
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumorsSujun Chen, Jessica Petricca, Wenbin Ye, et al.
Molecular Cell|February 20, 2021
DNA hypomethylating agents increase activation and cytolytic activity of CD8<sup>+</sup> T cellsHelen Loo Yau, Emma Bell, Ilias Ettayebi, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumorsKirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, et al.
Nature Medicine|September 8, 2020
Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomesPier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, et al.
Nature Medicine|June 24, 2020
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomesPier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Epigenomics|September 2, 2020
Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatmentMadonna R Peter, Misha Bilenky, Ruth Isserlin, et al.
Neuro-Oncology|December 1, 2022
Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classificationJeffrey A Zuccato, Vikas Patil, Sheila Mansouri, et al.
Frontiers in Immunology|August 21, 2023
The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell populationTiago S Medina, Alex Murison, Michelle Smith, et al.
Genome Biology|January 8, 2024
Modeling methyl-sensitive transcription factor motifs with an expanded epigenetic alphabetCoby Viner, Charles A Ishak, James Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2021
Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell CarcinomaJustin M Burgener, Jinfeng Zou, Zhen Zhao, et al.
Nature Communications|October 30, 2022
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumorsSujun Chen, Jessica Petricca, Wenbin Ye, et al.
Molecular Cell|February 20, 2021
DNA hypomethylating agents increase activation and cytolytic activity of CD8<sup>+</sup> T cellsHelen Loo Yau, Emma Bell, Ilias Ettayebi, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumorsKirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, et al.
Nature Medicine|September 8, 2020
Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomesPier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, et al.
Nature Medicine|June 24, 2020
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomesPier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, et al.
Pageof 3